- Short report
- Open Access
Preoperative Glucagon-like peptide-1 receptor imaging reduces surgical trauma and pancreatic tissue loss in insulinoma patients: a report of three cases
© Wenning et al.; licensee BioMed Central. 2015
- Received: 4 February 2015
- Accepted: 22 April 2015
- Published: 2 June 2015
Insulinomas are rare tumors, in the majority of cases best treated by surgical resection. Preoperative localization of insulinoma is challenging. The more precise the preoperative localization the less invasive and safer is the resection. The purpose of the study is to check the impact of a new technique to localize insulinoma on the surgical strategy.
We present exact preoperative localization with Glucagon-like peptide-1 receptor (GLP-1R) imaging. This allows a more precise resection thereby reducing surgical access trauma, loss of healthy pancreatic tissue and increasing safety and quality of the surgical intervention.
With the help of precise preoperative localization of insulinoma with GLP-1R imaging the surgeon is able to minimize the amount of resected healthy pancreatic tissue. We hypothesize that GLP-1R imaging will become a preoperative diagnostic tool to be used for many patients scheduled for open or laparoscopic insulinoma resection.
- Superior Mesenteric Vein
- Uncinate Process
- Preoperative Localization
- Pancreatic Tail
Precise preoperative localization of insulinoma is challenging. In 90% insulinomas are located in the pancreas, most of them with a size below 2 cm. In a recent systematic review computed tomography (CT) is described as diagnostic modality of choice and reaches a rate of correct localization of 44.4% . Magnetic resonance imaging (MRI) is an accepted alternative with a rate of correct localization of 47.4%. The sensitivity showed a wide variation between 2–95.3% for CT (mean 43.9%) and 0-100% for MRI (mean 53.3). With intraoperative ultrasound insulinomas of a size of 2-3 mm can be detected . The rate of correct localization was reviewed as 91.5% with a mean sensitivity of 91.2%. Therefore, open (or laparoscopic) surgical exploration combined with intraoperative ultrasound remains the preferred approach to localize insulinoma. Unfortunately, with this technique the entire pancreas needs to be surgically exposed if the preoperative CT and or MRI do not exactly show the localization of the insulinoma.
Glucagon-like peptide-1 receptor (GLP-1R) imaging using 111In-exendin-4 SPECT/CT has been shown to be more sensitive in detection of insulinoma than CT or MRI [3-5]. Until now, only case series have been published. In detail, in 2008 6 patients had a 100% correct preoperative localization rate. The following prospective multicenter study showed a sensitivity of 95% for the GLP-1R imaging in contrast to 47% for CT or MRI. Especially in patients without pathological findings in routine diagnostic GLP-1R imaging was helpful to localize insulinoma. However it is important to know that many malign insulinomas lack GLP-1R and will not be detectable by GLP-1R targeted imaging.
We hypothesize that exact preoperative localization with GLP-1R imaging allows for a more precise resection thereby reducing surgical access trauma, loss of healthy pancreatic tissue and increasing safety and quality of the surgical intervention.
We present three consecutive cases of insulinomas which are not included in previously published series and focus on surgical tactics and safety. Prior to surgery, all patients underwent GLP-1R imaging using 111In-DOTA-exendin-4 SPECT/CT in addition to CT or MRI. Synthesis and labelling of 111In-DOTA-exendin-4 was published elsewhere . SPECT/CT of the abdomen was performed at 4 and 72 hours after i.v. injection of 111In-DOTA-exendin-4. Surgery was done by one single surgical team (ASW and BG).
Preoperative imaging to localize insulinoma, intraoperative finding and surgical approach in three patients
Patient 1 (f)
Patient 2 (f)
Patient 3 (m)
Hypervascular lesion in uncinate process
Dorsal of uncinate process
Dorsal of uncinate process
Pancreatic tail resection
In all three patients GLP-1R imaging was crucial for planning the resection. Operation was performed pointing straight to the localization of interest. The access was kept as minimal as possible und healthy pancreatic tissue was preserved.
In the first patient preoperative imaging did not show the neuroendocrine tumor but falsely found a lesion in the uncinate process. With the help of the GLP-1R imaging we were able to keep surgical exploration of the uncinate process at a minimum.
In the third patient GLP-1R imaging led to laparoscopic resection. Laparoscopic sonography is an established method, but digital palpation cannot be used. Therefore only a reliable preoperative localization of insulinoma allows a safe and fast laparoscopic approach.
Based on these three cases and the previously published data we recommend preoperative GLP-1R imaging in insulinoma patients. Especially in ectopic or small lesions below a size of 1 cm and in MEN1 patients who sometimes suffer from multiple insulinomas or if preoperative imaging does not at all or not correctly show the lesion the benefit for our patients is high. Another advantage is the possibility to use the gamma-probe to detect an insulinoma intraoperatively, as long as the resection is planned less than 14 days after the scan . With these tools the risk for an unsuccessful operation is reduced to a minimum.
In our experience the preoperative GLP-1R imaging leads to focused access to the insulinoma, preservation of more normal pancreatic tissue and thus to a higher precision and safety of the procedure.
In our view preoperative GLP-1R imaging is important for planning surgical treatment in insulinoma. For the future it may allow to perform laparoscopic resections more frequently.
- Mehrabi A, Fischer L, Hafezi M, Dirlewanger A, Grenacher L, Diener MK, et al. A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas. 2014;43(5):675–86.View ArticlePubMedGoogle Scholar
- Shin LK, Brant-Zawadzki G, Kamaya A, Jeffrey RB. Intraoperative ultrasound of the pancreas. Ultrasound Q. 2009;25(1):39–48.View ArticlePubMedGoogle Scholar
- Christ E, Wild D, Ederer S, Behe M, Nicolas G, Caplin ME, et al. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol. 2013;1(2):115–22.View ArticlePubMedGoogle Scholar
- Christ E, Wild D, Forrer F, Brandle M, Sahli R, Clerici T, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metabolism. 2009;94(11):4398–405.View ArticleGoogle Scholar
- Wild D, Macke H, Christ E, Gloor B, Reubi JC. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med. 2008;359(7):766–8.View ArticlePubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.